Skip to main content

United States DC Circuit


IN RE: LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION, 01-7163

Challenges to class certification do not warrant interlocutory review pursuant to FRCP 23(f), where appellant failed to show that certification of the class would sound the "death knell" of the litigation, the challenge presents no unsettled question of fundamental importance to the law of class actions, or that class certification was manifestly erroneous.

Appellate Information

  • Argued 03/12/2002
  • Decided 05/14/2002
  • Published 05/14/2002

Judges

  • Before:  GINSBURG, Chief Judge, ROGERS and GARLAND, Circuit Judges.

Court

  • United States DC Circuit

Counsel

  • For Appellant:
  • John G. Roberts, Jr. argued the cause for petitioners.   With him on the briefs were Catherine E. Stetson, Michael R. Grynberg, Christopher K. Tahbaz, Irving Scher and David A. Hickerson.  James B. Weidner entered an appearance.

  • For Appellees:
  • Michael D. Hausfeld argued the cause for respondents.   With him on the brief were Arthur M. Kaplan and Thomas Campbell.
Copied to clipboard